All In MedTech

PMA device

FlexNav and Navitor Loading System, FlexNav Delivery System

Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

1

PMA pathway

Device trials

8

Naming "FlexNav"

MAUDE reports

746

Brand "FlexNav", since 2015

PubMed studies

13

Mentioning "FlexNav"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing FlexNav and Navitor Loading System, FlexNav Delivery System

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 1 of 1 decisions filed under this name.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

Clinical trials

Device studies on ClinicalTrials.gov that name "FlexNav", any status and sponsor, newest update first.

Open in Trial Radar
  • Abbott Medical DevicesPublic (ABT)

    NCT04011722 · 333 participants · Start Sep 17, 2019 · Primary completion Jan 12, 2023

    Device: Portico™ NG (Navitor) Valve and FlexNav™ Delivery System; Navitor Titan Valve (35mm) Valve and Large FlexNav™ Delivery System · For: Symptomatic Severe Aortic Stenosis

    Sites: Los Angeles, California; Thousand Oaks, California; Washington D.C., District of Columbia · 28 sites in all

  • Abbott Medical DevicesPublic (ABT)

    NCT06008080 · 1,000 participants (planned) · Start Sep 29, 2023 · Primary completion Jul 2027

    Device: Navitor Transcatheter Aortic Valve, FlexNav Delivery System, Navitor Loading System · For: Aortic Stenosis

    Sites: Adelaide, Australia; Hobart, Australia; Melbourne, Australia · 50 sites in all

  • Abbott Medical DevicesPublic (ABT)

    NCT07193888 · 100 participants (planned) · Start Oct 30, 2025 · Primary completion Jul 2028

    Device: Navitor Transcatheter Aortic Valve Implantation · For: Severe Aortic Stenosis

    Sites: Fukuoka, Japan; Kanagawa, Japan; Osaka, Japan

5 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "FlexNav", and for the whole product code for context.

This brand

746 reports: 423 malfunction, 289 injury, 34 death

Whole product code NPT

77,669 reports: 12,243 malfunction, 57,723 injury, 7,693 death

Newest reports for this brand

2 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

2 more recall records with a free account

Published research

The most relevant PubMed records for "FlexNav"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

Other devices of this type

Also filed under product code NPT.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.